{"product_id":"harvard-infectious-diseases-in-adults-2026","title":"Harvard Infectious Diseases In Adults 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: infectious disease physicians, internists, hospital medicine physicians, family practice physicians, pulmonologists, critical care medicine physicians, emergency medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eInfectious Diseases in Adults 2026 provides state-of-the-art approaches for the prevention, diagnosis, and management of infectious diseases: common, challenging, rare, and emerging.\u003c\/p\u003e\n\u003cp\u003eState-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases in Adults\u003c\/p\u003e\n\u003ch3\u003eThis comprehensive CME program, now in its 50th year, ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:\u003c\/h3\u003e\n\u003cp\u003eOptimal decision-making across a range of common and unusual infectious diseases\u003c\/p\u003e\n\u003cp\u003eNewer antimicrobials and treatment strategies for highly resistant infections\u003c\/p\u003e\n\u003cp\u003ePrevention and treatment of infections in immunocompromised hosts\u003c\/p\u003e\n\u003cp\u003eUpdate on antifungal diagnostics and therapy\u003c\/p\u003e\n\u003cp\u003eState-of-the-art and multidisciplinary approaches to common infections\u003c\/p\u003e\n\u003cp\u003eClinical approaches to complex, rare, and “don’t-miss” infections\u003c\/p\u003e\n\u003cp\u003eNew, evolving, emerging, and re-emerging infectious diseases\u003c\/p\u003e\n\u003cp\u003eInfections in persons with substance use disorder\u003c\/p\u003e\n\u003cp\u003eWhat’s new in HIV prevention and management\u003c\/p\u003e\n\u003cp\u003eThe latest on COVID-19, including long COVID\u003c\/p\u003e\n\u003cp\u003eAdult vaccinations in 2026\u003c\/p\u003e\n\u003cp\u003eIn addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 90 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 60 days of the conclusion of the course to receive CME credit.)\u003c\/p\u003e\n\u003cp\u003eHighlights of the 2026 Program\u003c\/p\u003e\n\u003cp\u003eExpanded Case-Based and Problem-Solving Education\u003c\/p\u003e\n\u003cp\u003eThe 2026 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions to our national experts in live question-and-answer sessions following the lectures and the multidisciplinary workshops.\u003c\/p\u003e\n\u003cp\u003eOur speakers and panelists include not only ID experts, but those from fields such as pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care.\u003c\/p\u003e\n\u003cp\u003eOur ten multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, resistant Gram-positive and Gram-negative infections, management of endocarditis and cardiac device infections, musculoskeletal infections, and nontuberculous mycobacterial infections.\u003c\/p\u003e\n\u003ch3\u003eTreating Highly Resistant Infections, including:\u003c\/h3\u003e\n\u003cp\u003eMRSA and VISA (vancomycin-intermediate Staph aureus)\u003c\/p\u003e\n\u003cp\u003eExtended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods\u003c\/p\u003e\n\u003cp\u003eCarbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms\u003c\/p\u003e\n\u003cp\u003eVancomycin-resistant enterococci (VRE)\u003c\/p\u003e\n\u003cp\u003eResistant fungal infections, including Aspergillus, other molds, and resistant Candidal infections\u003c\/p\u003e\n\u003cp\u003eNontuberculous mycobacteria (NTM)\u003c\/p\u003e\n\u003ch3\u003eCommon Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment, including:\u003c\/h3\u003e\n\u003cp\u003eRespiratory viral infections, including COVID-19\u003c\/p\u003e\n\u003cp\u003eNew and updated vaccine guidance\u003c\/p\u003e\n\u003cp\u003eInfections in the expanding populations of immunocompromised hosts\u003c\/p\u003e\n\u003cp\u003eInfections in persons with substance use disorder\u003c\/p\u003e\n\u003cp\u003eInfections of travelers and foreign-born persons\u003c\/p\u003e\n\u003cp\u003eSystemic fungal infections\u003c\/p\u003e\n\u003cp\u003eNative and device-related orthopedic infections\u003c\/p\u003e\n\u003cp\u003eCentral nervous system (CNS) infections\u003c\/p\u003e\n\u003cp\u003eNative and prosthetic valve endocarditis, and cardiac device infections\u003c\/p\u003e\n\u003cp\u003eEar, nose, and throat (ENT) and eye infections\u003c\/p\u003e\n\u003cp\u003eSkin and soft tissue infections\u003c\/p\u003e\n\u003cp\u003eBronchiectasis and pneumonia\u003c\/p\u003e\n\u003cp\u003eHIV and its infectious and noninfectious complications\u003c\/p\u003e\n\u003cp\u003ePEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection\u003c\/p\u003e\n\u003cp\u003eSexually transmitted infections (STIs), including mpox and PEP for prevention of STIs\u003c\/p\u003e\n\u003cp\u003eHepatitis B and C infections\u003c\/p\u003e\n\u003cp\u003eTick- and mosquito-borne infections\u003c\/p\u003e\n\u003cp\u003eClostridioides difficile infection, the gut microbiome, and pre- and probiotics\u003c\/p\u003e\n\u003cp\u003eComplicated urinary tract infections\u003c\/p\u003e\n\u003cp\u003eIntra-abdominal infections\u003c\/p\u003e\n\u003ch3\u003eChallenging, Rare, and Emerging Infectious Diseases, including:\u003c\/h3\u003e\n\u003cp\u003eHighly pathogenic avian flu\u003c\/p\u003e\n\u003cp\u003eRe-emergence of vaccine-preventable diseases, including poliomyelitis\u003c\/p\u003e\n\u003cp\u003ePulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus\u003c\/p\u003e\n\u003cp\u003eGlobal infectious diseases of clinical importance\u003c\/p\u003e\n\u003cp\u003eClinical Decision-Making\u003c\/p\u003e\n\u003ch3\u003eHear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:\u003c\/h3\u003e\n\u003cp\u003eSelecting the best antimicrobial and duration of treatment\u003c\/p\u003e\n\u003cp\u003eRapid detection and empiric treatment of life-threatening infectious diseases\u003c\/p\u003e\n\u003cp\u003eChoosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials\u003c\/p\u003e\n\u003cp\u003eOptimizing empiric antimicrobial therapy: what to start, and how and when to de-escalate\u003c\/p\u003e\n\u003ch3\u003eOur multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:\u003c\/h3\u003e\n\u003cp\u003eAntimicrobial stewardship to prevent resistance and reduce cost\u003c\/p\u003e\n\u003cp\u003eEarly inpatient ID consultations to improve outcomes\u003c\/p\u003e\n\u003cp\u003eStrategies for management of infection in persons who inject drugs (PWID)\u003c\/p\u003e\n\u003cp\u003eNew in 2026: Advanced Learning Modules\u003c\/p\u003e\n\u003cp\u003eHIV\u003c\/p\u003e\n\u003cp\u003eMycobacterial Infections\u003c\/p\u003e\n\u003cp\u003eEach of these expanded learning modules provides advanced content for learners seeking to build additional expertise in these two important areas. These modules offer on-demand, self-paced lectures as well as live Meet-the-Professors sessions, where our expert faculty discuss cases submitted by our course participants.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eUtilize the latest strategies for the prevention, diagnosis, and management of important infectious disease syndromes in immunocompetent and immunocompromised patients\u003c\/p\u003e\n\u003cp\u003eDescribe updated guidelines on the treatment of infectious diseases\u003c\/p\u003e\n\u003cp\u003eSummarize principles of judicious antimicrobial selection, dose, route, and duration to optimize patient outcomes while preventing resistance and lowering cost\u003c\/p\u003e\n\u003cp\u003eDescribe evidence-based treatments as well as new treatment paradigms for resistant organisms and difficult-to-treat infections\u003c\/p\u003e\n\u003cp\u003eRecognize the role of novel, rapid diagnostics of infection and resistance in infectious disease practice\u003c\/p\u003e\n\u003cp\u003eRecognize the epidemiologic risk factors for emerging infectious diseases and provide optimal empiric and target therapies for infections\u003c\/p\u003e\n\u003cp\u003eDesign and implement multidisciplinary care for patients in areas such as hematology oncology, solid organ transplantation, musculoskeletal infections, endocarditis, abdominal infections, and genitourinary infections\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for infectious disease physicians and internists who want updates on antimicrobial stewardship, HIV, and managing complex infections.\u003c\/p\u003e\n\u003cp\u003eWho Should Participate\u003c\/p\u003e\n\u003ch3\u003ePhysicians, Nurse Practitioners, Physician Assistants, and Pharmacists in the fields of:\u003c\/h3\u003e\n\u003cp\u003eInfectious Diseases\u003c\/p\u003e\n\u003cp\u003eHospital Medicine\u003c\/p\u003e\n\u003cp\u003eInternal Medicine\u003c\/p\u003e\n\u003cp\u003eFamily Practice\u003c\/p\u003e\n\u003cp\u003ePulmonary and Critical Care Medicine\u003c\/p\u003e\n\u003cp\u003eEmergency Medicine\u003c\/p\u003e\n\u003cp\u003e…and others who care for patients with infectious diseases\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 Advancing Patient Care Through Antimicrobial Stewardship\u003c\/p\u003e\n\u003cp\u003e02 Update on Antifungal Diagnostics and Therapy\u003c\/p\u003e\n\u003cp\u003e03 Plenary The Future of Global Public Health Lessons from HIV\u003c\/p\u003e\n\u003cp\u003e04 Live Q\u0026amp;A Dr. Linda-Gail Bekker\u003c\/p\u003e\n\u003cp\u003e05 Eye and ENT Infections What You Need to Know in 2026\u003c\/p\u003e\n\u003cp\u003e06 Live Q\u0026amp;A Drs. Miriam Barshak, Nesli Basgoz, Alyssa Letourneau, and Michael Mansour\u003c\/p\u003e\n\u003cp\u003e07 Multidisciplinary Panel Workshop 1 Resistant Gram-Positive Infections\u003c\/p\u003e\n\u003cp\u003e08 Multidisciplinary Panel Workshop 2 Resistant Gram-Negative Infections\u003c\/p\u003e\n\u003cp\u003e09 Live Q\u0026amp;A Drs. Alyssa Letourneau, Roby Bhattacharyya, Cecilia Li, and Tiffany Wu\u003c\/p\u003e\n\u003cp\u003e10 C. difficile Update, the Gut Microbiome, and Pre- and Probiotics\u003c\/p\u003e\n\u003cp\u003e11 Skin and Soft Tissue Infections Current Best Practices for Clinicians\u003c\/p\u003e\n\u003cp\u003e12 Live Q\u0026amp;A Drs. Sandra Nelson and Elizabeth Hohmann\u003c\/p\u003e\n\u003cp\u003e13 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy\u003c\/p\u003e\n\u003cp\u003e14 Infections in Hematologic Malignancies and Stem Cell Transplantation\u003c\/p\u003e\n\u003cp\u003e15 Flummoxing Cases in Fungal Infections\u003c\/p\u003e\n\u003cp\u003e16 Live Q\u0026amp;A Drs. Camille Kotton, Michael Mansour, Sarah Hammond, and Sarah Turbett\u003c\/p\u003e\n\u003cp\u003e17 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections\u003c\/p\u003e\n\u003cp\u003e19 Navigating New Vaccines Updates and Recommendations\u003c\/p\u003e\n\u003cp\u003e20 Pre- and Post-Exposure Prophylaxis for HIV and STIs\u003c\/p\u003e\n\u003cp\u003e21 What’s New in the Care of People with HIV in 2026\u003c\/p\u003e\n\u003cp\u003e22 Addressing the Continuing Challenges in HIV-Associated Opportunistic Infections\u003c\/p\u003e\n\u003cp\u003e23 Live Q\u0026amp;A Drs. Rajesh Gandhi, Nesli Basgoz, Kevin Ard, and Camille Kotton\u003c\/p\u003e\n\u003cp\u003e24 Self-Paced Study HIV Perinatal HIV Infection\u003c\/p\u003e\n\u003cp\u003e25 Self-Paced Study HIV Perinatal Metabolic Complications of HIV\u003c\/p\u003e\n\u003cp\u003e26 Self-Paced Study HIV Perinatal CROI Updates\u003c\/p\u003e\n\u003cp\u003e27 Self-Paced Study HIV Perinatal HIV Resistance\u003c\/p\u003e\n\u003cp\u003e28 Introduction to TB, Latent TB Infection, and Drug-Susceptible TB\u003c\/p\u003e\n\u003cp\u003e29 Drug-Resistant TB and TB in Special Populations\u003c\/p\u003e\n\u003cp\u003e30 Live Q\u0026amp;A Drs. Rocio Hurtado and Jodian Pinkney\u003c\/p\u003e\n\u003cp\u003e31 Bronchiectasis and NTM Infections Anatomic and Clinical Approaches\u003c\/p\u003e\n\u003cp\u003e32 The Latest on Major Respiratory Viral Infections\u003c\/p\u003e\n\u003cp\u003e33 Innovations in HBV and HCV Care Updates for 2026\u003c\/p\u003e\n\u003cp\u003e34 Live Q\u0026amp;A Drs. Nesli Basgoz, Arthur Kim, and Michael Ison\u003c\/p\u003e\n\u003cp\u003e35 Live New England Journal of Medicine Clinicopathologic Conference (CPC) Please note This event will not be recorded\u003c\/p\u003e\n\u003cp\u003e37 Global Infectious Diseases Case-Based Updates\u003c\/p\u003e\n\u003cp\u003e38 Live Q\u0026amp;A Dr. Edward T. Ryan\u003c\/p\u003e\n\u003cp\u003e39 Multidisciplinary Panel Workshop 3 Management of Complex Nontuberculous Mycobacterial Infection (NTM) Pulmonary\u003c\/p\u003e\n\u003cp\u003e40 Multidisciplinary Panel Workshop 4 Management of Complex Nontuberculous Mycobacterial Infection (NTM) Extrapulmonary\u003c\/p\u003e\n\u003cp\u003e41 Live Q\u0026amp;A Drs. Rocio Hurtado, Michael Lanuti, Christopher Richards, Kristen Hysell, Alex Rock, and Alyssa Letourneau\u003c\/p\u003e\n\u003cp\u003e42 Encephalitis and Meningitis Guidelines and Best Practices\u003c\/p\u003e\n\u003cp\u003e43 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, and Rickettsia\u003c\/p\u003e\n\u003cp\u003e44 Live Q\u0026amp;A Drs. Allan Tunkel and Kimon Zachary\u003c\/p\u003e\n\u003cp\u003e45 Bone and Joint infections A Conceptual Framework\u003c\/p\u003e\n\u003cp\u003e46 Staphylococcus aureus Déjà Vu All Over Again\u003c\/p\u003e\n\u003cp\u003e47 Live Q\u0026amp;A Drs. Sandra Nelson and Henry Chambers\u003c\/p\u003e\n\u003cp\u003e48 Multidisciplinary Panel Workshop 5 Native Bone Infections\u003c\/p\u003e\n\u003cp\u003e49 Multidisciplinary Panel Workshop 6 Orthopedic Device Infections Prosthetic Joint Infections\u003c\/p\u003e\n\u003cp\u003e50 Live Q\u0026amp;A Drs. Sandra Nelson, Hayden Box, F. Joseph Simeone, and Jeremy Goverman VIDEO NOT RELEASE\u003c\/p\u003e\n\u003cp\u003e51 New and Emerging Viruses Clinical Insights for Frontline Providers and ID Specialists\u003c\/p\u003e\n\u003cp\u003e52 KEYNOTE Polio The Unfinished Story\u003c\/p\u003e\n\u003cp\u003e53 Live Q\u0026amp;A Drs. Martin Hirsch and David Oshinsky VIDEO NOT RELEASE\u003c\/p\u003e\n\u003cp\u003e54 Intra-abdominal Infections A Conceptual Framework\u003c\/p\u003e\n\u003cp\u003e55 Urinary Tract Infections A Conceptual Framework\u003c\/p\u003e\n\u003cp\u003e56 Critical Care ID and Sepsis for the ID Clinician\u003c\/p\u003e\n\u003cp\u003e57 Live Q\u0026amp;A Drs. Nesli Basgoz, Jacob Lazarus, and Lisa Bebell VIDEO NOT RELEASE\u003c\/p\u003e\n\u003cp\u003e58 Multidisciplinary Workshop 7 Management of Complex Intra-abdominal Infections\u003c\/p\u003e\n\u003cp\u003e59 Multidisciplinary Workshop 8 Management of Complex Urinary Tract Infections\u003c\/p\u003e\n\u003cp\u003e60 Live Q\u0026amp;A Drs. Nesli Basgoz, Jacob Lazarus, Peter Fagenholz, Vincent Wu, Kristen Hung, and Lori Jones\u003c\/p\u003e\n\u003cp\u003e61 Endocarditis and Cardiac Device Infections\u003c\/p\u003e\n\u003cp\u003e62 The Syndemic of SUD and Infection Updated Approaches for 2026\u003c\/p\u003e\n\u003cp\u003e63 Live Q\u0026amp;A Drs. Molly Paras and Jennifer Johnson\u003c\/p\u003e\n\u003cp\u003e64 Multidisciplinary Workshop 9 Management of Endocarditis\u003c\/p\u003e\n\u003cp\u003e65 Multidisciplinary Workshop 10 Management of Cardiac Device Infections\u003c\/p\u003e\n\u003cp\u003e66 Live Q\u0026amp;A Drs. Molly Paras, Anne Duckles, Arminder Jassar, Shaan Khurshid, and Evin Yucel\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405752717508,"sku":null,"price":143.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Infectious-Diseases-In-Adults-2026.jpg?v=1784215674","url":"https:\/\/medicalcoursespro.com\/products\/harvard-infectious-diseases-in-adults-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}